The Lidocaine HCl 5 mg Oral Troche is a square-shaped solid dosage form intended for buccal administration. This troche is designed to dissolve slowly in the mouth, allowing for the gradual release of lidocaine hydrochloride. The medication is absorbed through the oral mucosa, providing targeted local anesthetic effects to alleviate pain and discomfort. This formulation is commonly used to treat various disease states, including but not limited to, oral mucosal lesions, mouth ulcers, and other conditions where local anesthesia of the oral tissues is required. The troche's unique delivery system ensures that the active ingredient is directly applied to the affected area, minimizing systemic absorption and potential side effects.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Lidocaine HCl 5 mg Oral Troche is a square-shaped solid dosage form specifically compounded to dissolve slowly in the mouth, providing a local anesthetic effect through the absorption of the active ingredient, Lidocaine HCl, via the oral mucosa. This formulation is designed to deliver a targeted local or systemic effect, depending on the specific needs of the patient. Lidocaine is a well-known local anesthetic and antiarrhythmic drug that works by blocking sodium channels, which in turn inhibits the initiation and conduction of nerve impulses. When administered as an oral troche, Lidocaine provides localized relief from various conditions that cause pain or discomfort in the oral and pharyngeal regions.
The Lidocaine HCl 5 mg Oral Troche is commonly used in the management of conditions such as sore throat, oral ulcers, and other mucosal conditions that cause pain and discomfort. It is also employed in dental procedures as a pre-anesthetic to alleviate pain before treatment. Additionally, it can be used for symptomatic relief of neuropathic pain or to manage pain from certain gastrointestinal procedures. The slow dissolution of the troche ensures a sustained release of Lidocaine, providing prolonged analgesic effects directly at the site of application.
For patients, it is important to use the Lidocaine HCl Oral Troche as directed by a healthcare provider. The troche should be placed in the mouth and allowed to dissolve slowly, without chewing or swallowing, to ensure the medication is absorbed through the oral mucosa. Patients should be aware of potential side effects, such as numbness of the tongue or mucosa, which are generally mild and temporary. For prescribers, it is crucial to consider the patient's medical history, including any known allergies to local anesthetics, and to provide clear instructions on the use of the troche to ensure safety and efficacy.
Bayview Pharmacy's team of compounding pharmacists is dedicated to providing high-quality, customized medications to meet the unique needs of each patient. Our pharmacists are available to answer any questions and provide additional information to both patients and prescribers regarding the Lidocaine HCl 5 mg Oral Troche formulation. If you have any questions or require further assistance, please do not hesitate to reach out to us at Bayview Pharmacy.
Lidocaine HCl 5 mg oral troches are square-shaped solid dosage forms designed to dissolve slowly in the mouth, allowing for the medication to be absorbed through the oral mucosa. This delivery method can provide targeted local anesthesia or systemic analgesic effects. Lidocaine is primarily used to relieve and manage pain due to conditions such as mouth ulcers, sore throat, or dental procedures. It works by blocking sodium channels and thus inhibiting the initiation and conduction of nerve impulses, providing a numbing sensation and pain relief.
When considering the use of lidocaine oral troches, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects. Lidocaine is metabolized by the liver, and drugs that affect liver enzymes, particularly cytochrome P450 isoenzymes such as CYP1A2 and CYP3A4, can alter the levels of lidocaine in the body. For example, medications that inhibit these enzymes, such as cimetidine, fluvoxamine, and ketoconazole, may increase lidocaine concentrations, potentially leading to toxicity. Conversely, inducers of these enzymes, such as rifampin and phenytoin, may decrease lidocaine levels, reducing its effectiveness.
Additionally, lidocaine has the potential to interact with other local anesthetics or medications that have a similar mechanism of action, which could lead to additive systemic effects such as CNS depression or cardiovascular effects. Caution is advised when using lidocaine in conjunction with antiarrhythmic drugs, such as mexiletine, as both drugs can have additive effects on the heart, potentially leading to cardiac abnormalities. Beta-blockers and calcium channel blockers may also interact with lidocaine, increasing the risk of bradycardia or hypotension.
Patients with pre-existing heart conditions, liver disease, or those taking multiple medications should use lidocaine oral troches with caution. It is crucial to inform the healthcare provider of all medications, supplements, and herbal products being taken before starting treatment with lidocaine troches to avoid potential interactions. Monitoring for signs of toxicity, such as CNS symptoms (dizziness, confusion, tremors) or cardiac issues (irregular heartbeat, chest pain), is important, especially in patients with risk factors for increased lidocaine levels.
For any questions or concerns regarding the use of lidocaine HCl 5 mg oral troches, including potential drug interactions and disease state management, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to provide in-depth information and guidance to ensure appropriate treatment for both patients and prescribers.
Lidocaine HCl 5 mg Oral Troches are square-shaped solid dosage forms that are specifically designed to dissolve slowly in the mouth. This unique delivery system allows for the medication to be absorbed directly through the oral mucosa, which is the mucous membrane lining the inside of the mouth. The advantage of this route of administration is that it bypasses the digestive system and the first-pass metabolism in the liver, potentially reducing systemic side effects and allowing for a more rapid onset of action.
The active ingredient in these troches, Lidocaine HCl, is a local anesthetic that works by blocking sodium channels in the neuronal cell membrane. This action inhibits the initiation and conduction of nerve impulses, thereby providing a numbing effect. When a Lidocaine HCl troche is placed in the mouth and allowed to dissolve, the medication is released gradually and absorbed through the oral tissues. This can provide localized pain relief in the oral cavity, which can be beneficial for conditions such as mouth ulcers, sore throat, or other painful oral lesions. Additionally, it can be used as an anesthetic before procedures that involve the mouth or throat.
For systemic effects, the absorption through the oral mucosa allows the medication to enter the bloodstream directly. This can be useful in certain medical conditions where a rapid onset of action is desired, or where swallowing pills is difficult or contraindicated. However, it is important to note that while the primary intention of Lidocaine HCl troches is for local effect, some systemic absorption will occur, and the prescriber should consider this when determining the appropriate dosage and frequency of administration.
Patients with a history of hypersensitivity to local anesthetics of the amide type, severe liver disease, or heart conduction problems should avoid using this medication unless advised otherwise by a healthcare professional. Additionally, the use of this medication should be closely monitored in children, elderly patients, and those with compromised health conditions.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the specific needs of our patients. If you have any questions about Lidocaine HCl 5 mg Oral Troches or would like to discuss whether this formulation is appropriate for your condition, please do not hesitate to reach out to us.
A Lidocaine HCl 5 mg Oral Troche is a square-shaped solid dosage form containing 5 milligrams of Lidocaine Hydrochloride. It is designed to dissolve slowly in the mouth, with the medication being absorbed through the oral mucosa, providing targeted local or systemic relief.
The active ingredient in the troche, Lidocaine HCl, works by numbing the tissue in the oral cavity. As the troche dissolves, the medication is gradually released and absorbed through the lining of the mouth, leading to pain relief or other intended therapeutic effects.
Lidocaine HCl Oral Troches are commonly used to relieve oral pain, treat mouth ulcers, or provide anesthesia for dental procedures. They may also be indicated for other conditions as determined by a healthcare provider.
Place the troche in your mouth and allow it to dissolve slowly, usually over a 20-30 minute period. Do not chew or swallow the troche whole. Follow your healthcare provider's specific instructions regarding dosage and frequency of use.
Some individuals may experience side effects such as a mild burning sensation, changes in taste, or numbness in the mouth where the troche is dissolving. If you experience any severe reactions or symptoms of an allergic reaction, seek medical attention immediately.
While many people can use Lidocaine Troches, they may not be suitable for everyone. Patients with a history of hypersensitivity to local anesthetics of the amide type or to other components of the troche should avoid use. Always consult with a healthcare provider before starting any new medication.
Store the troches at room temperature, away from moisture and heat, and keep them out of the reach of children and pets. Do not use the medication beyond its expiration date.
If you miss a dose, take the troche as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Yes, Lidocaine HCl can interact with certain medications and may cause adverse effects. It is important to inform your healthcare provider of all medications and supplements you are taking before starting treatment with Lidocaine Troches.
Coverage for compounded formulations like Lidocaine HCl Oral Troches can vary by insurance provider. You should check with your insurance company to determine if this medication is covered under your plan.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve